-
1
-
-
1642273148
-
Breast cancer from a public health perspective
-
R.R. Love S.M. Love A.V. Laudico Breast cancer from a public health perspective Breast J 10 2004 136-140
-
(2004)
Breast J.
, vol.10
, pp. 136-140
-
-
Love, R.R.1
Love, S.M.2
Laudico, A.V.3
-
2
-
-
15844425226
-
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: Meta analysis of quality-adjusted survival
-
R.D. Gelber B.F. Cole A. Goldhirsch C. Rose B. Fisher C.K. Osborne et al. Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: Meta analysis of quality-adjusted survival Lancet 347 1996 1057-1058
-
(1996)
Lancet
, vol.347
, pp. 1057-1058
-
-
Gelber, R.D.1
Cole, B.F.2
Goldhirsch, A.3
Rose, C.4
Fisher, B.5
Osborne, C.K.6
-
3
-
-
0037240367
-
Adjuvant hormonal therapy for premenopausal women with breast cancer
-
L.A. Emens N.E. Davidson Adjuvant hormonal therapy for premenopausal women with breast cancer Clin Cancer Res 9 Suppl. 2003 468s-494s
-
(2003)
Clin. Cancer Res.
, vol.9
, Issue.SUPPL.
-
-
Emens, L.A.1
Davidson, N.E.2
-
4
-
-
13244268450
-
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: Cohort study
-
G. Bonadonna A. Moliterni M. Zambetti M.G. Daidone S. Pilotti L. Gianni et al. 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: Cohort study BMJ 330 2005 217
-
(2005)
BMJ
, vol.330
, pp. 217
-
-
Bonadonna, G.1
Moliterni, A.2
Zambetti, M.3
Daidone, M.G.4
Pilotti, S.5
Gianni, L.6
-
5
-
-
0842308445
-
First-line endocrine treatment of breast cancer: Aromatase inhibitor or antiestrogen
-
Z.W. Wong M.J. Ellis First-line endocrine treatment of breast cancer: aromatase inhibitor or antiestrogen Br J Cancer 90 2004 20-25
-
(2004)
Br. J. Cancer
, vol.90
, pp. 20-25
-
-
Wong, Z.W.1
Ellis, M.J.2
-
6
-
-
0035687926
-
A longitudinal study of health related quality of life and utility measures in patients with advanced breast cancer
-
D.J. Perez S.M. Williams E.A. Christensen R.O. McGee A.V. Campbell A longitudinal study of health related quality of life and utility measures in patients with advanced breast cancer Qual Life Res 10 2001 587-593
-
(2001)
Qual. Life Res.
, vol.10
, pp. 587-593
-
-
Perez, D.J.1
Williams, S.M.2
Christensen, E.A.3
McGee, R.O.4
Campbell, A.V.5
-
7
-
-
0037005895
-
Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study
-
P.A. Ganz K.A. Desmond B. Leedham J.H. Rowland B.E. Meyerowitz T.R. Belin Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study J Natl Cancer Inst 94 2002 39-49
-
(2002)
J. Natl. Cancer Inst.
, vol.94
, pp. 39-49
-
-
Ganz, P.A.1
Desmond, K.A.2
Leedham, B.3
Rowland, J.H.4
Meyerowitz, B.E.5
Belin, T.R.6
-
8
-
-
7044238403
-
Same gain, less pain: Potential patient preferences for adjuvant treatment in premenopausal women with early breast cancer
-
L. Fallowfield R. McGurk M. Dixon Same gain, less pain: Potential patient preferences for adjuvant treatment in premenopausal women with early breast cancer Eur J Cancer 40 2004 2403-2410
-
(2004)
Eur. J. Cancer
, vol.40
, pp. 2403-2410
-
-
Fallowfield, L.1
McGurk, R.2
Dixon, M.3
-
9
-
-
0037453905
-
Health-related quality of life measurement in randomized clinical trials in breast cancer - Taking stock
-
P.J. Goodwin J.T. Black L.J. Bordeleau P.A. Ganz Health-related quality of life measurement in randomized clinical trials in breast cancer - taking stock J Natl Cancer Inst 95 2003 263-281
-
(2003)
J. Natl. Cancer Inst.
, vol.95
, pp. 263-281
-
-
Goodwin, P.J.1
Black, J.T.2
Bordeleau, L.J.3
Ganz, P.A.4
-
10
-
-
0029803177
-
Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+methotrexate+fluorouracil in patients with node-positive breast cancer
-
A. Messori P. Becagli S. Trippoli E. Tendi Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide+methotrexate+fluorouracil in patients with node-positive breast cancer Eur J Clin Pharmacol 51 1996 111-116
-
(1996)
Eur. J. Clin. Pharmacol.
, vol.51
, pp. 111-116
-
-
Messori, A.1
Becagli, P.2
Trippoli, S.3
Tendi, E.4
-
11
-
-
0034002168
-
Adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF) in breast cancer - Is it cost effective?
-
J. Norum Adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF) in breast cancer - is it cost effective? Acta Oncol 39 2000 33-39
-
(2000)
Acta Oncol.
, vol.39
, pp. 33-39
-
-
Norum, J.1
-
12
-
-
0027474520
-
Should the elderly receive chemotherapy for node-negative breast cancer? Cost-effectiveness analysis examining total and active life-expectancy outcomes
-
C.E. Desch B.E. Hillner T.E. Smith S.M. Retchin Should the elderly receive chemotherapy for node-negative breast cancer? Cost-effectiveness analysis examining total and active life-expectancy outcomes J Clin Oncol 11 1993 777-782
-
(1993)
J. Clin. Oncol.
, vol.11
, pp. 777-782
-
-
Desch, C.E.1
Hillner, B.E.2
Smith, T.E.3
Retchin, S.M.4
-
13
-
-
0026020636
-
Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model
-
B.E. Hillner T.E. Smith Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model N Engl J Med 17 1991 160-168
-
(1991)
N. Engl. J. Med.
, vol.17
, pp. 160-168
-
-
Hillner, B.E.1
Smith, T.E.2
-
14
-
-
10644285714
-
Is adjuvant therapy for older patients with node (-) early breast cancer cost-effective
-
A. Naeim E.B. Keeler Is adjuvant therapy for older patients with node (-) early breast cancer cost-effective Crit Rev Oncol Hematol 53 2005 81-89
-
(2005)
Crit. Rev. Oncol. Hematol.
, vol.53
, pp. 81-89
-
-
Naeim, A.1
Keeler, E.B.2
-
15
-
-
0036211226
-
Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: A stochastic economic evaluation
-
Adjuvant Breast Cancer (ABC) Steering Committee
-
J. Karnon J. Brown Adjuvant Breast Cancer (ABC) Steering Committee. Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: A stochastic economic evaluation Pharmacoeconomics 20 2002 119-137
-
(2002)
Pharmacoeconomics
, vol.20
, pp. 119-137
-
-
Karnon, J.1
Brown, J.2
-
16
-
-
0027400930
-
The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women
-
T.J. Smith B.E. Hillner The efficacy and cost-effectiveness of adjuvant therapy of early breast cancer in premenopausal women J Clin Oncol 11 1993 771-776
-
(1993)
J. Clin. Oncol.
, vol.11
, pp. 771-776
-
-
Smith, T.J.1
Hillner, B.E.2
-
17
-
-
4444291699
-
Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early stage estrogen receptor-positive breast cancer
-
B.E. Hillner Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early stage estrogen receptor-positive breast cancer Cancer 101 2004 1311-1322
-
(2004)
Cancer
, vol.101
, pp. 1311-1322
-
-
Hillner, B.E.1
-
18
-
-
0003193675
-
Systemic therapy of early breast cancer by hormonal, cytotoxic ore immune therapy
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Systemic therapy of early breast cancer by hormonal, cytotoxic ore immune therapy Lancet 339 1992 1-15
-
(1992)
Lancet
, vol.339
, pp. 1-15
-
-
-
21
-
-
11444251764
-
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
-
ATAC Trialists' Group
-
ATAC Trialists' Group Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer Lancet 365 2005 60-62
-
(2005)
Lancet
, vol.365
, pp. 60-62
-
-
|